UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Haematologica (Roma), 2010-03, Vol.95 (3), p.415-423

2010

Volltextzugriff (PDF)

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Haematologica (Roma), 2009-12, Vol.94 (12), p.1676-1681

2009

Volltextzugriff (PDF)

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Haematologica (Roma), 2012-02, Vol.97 (2), p.213-218

2012

Volltextzugriff (PDF)

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Nature communications, 2021-09, Vol.12 (1), p.5346-5346, Article 5346

2021

Volltextzugriff (PDF)

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Blood, 2005-05, Vol.105 (10), p.4035-4042

2005

Volltextzugriff (PDF)

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

Haematologica (Roma), 2011-07, Vol.96 (7), p.1059-1063

2011

Volltextzugriff (PDF)

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Blood, 2002-03, Vol.99 (5), p.1594-1601

2002

Volltextzugriff (PDF)

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Haematologica (Roma), 2010-06, Vol.95 (6), p.892-899

2010

Volltextzugriff (PDF)

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9742-9754

2010

Volltextzugriff (PDF)

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Blood cancer journal (New York), 2017-06, Vol.7 (6), p.e568-e568

2017

Volltextzugriff (PDF)

Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide

Leukemia research, 2008-07, Vol.32 (7), p.1049-1053

2008

Volltextzugriff (PDF)

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

Leukemia research, 2015-03, Vol.39 (3), p.296-306

2015

Volltextzugriff (PDF)

Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?

Leukemia research, 2012-04, Vol.36 (4), p.397-400

2012

Volltextzugriff (PDF)

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS

Leukemia research, 2011-11, Vol.35 (11), p.1530-1533

2011

Volltextzugriff (PDF)

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

The Journal of hospital infection, 2002-08, Vol.51 (4), p.288-296

2002

Volltextzugriff (PDF)

Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

Leukemia research, 2009-04, Vol.33 (4), p.547-550

2009

Volltextzugriff (PDF)

Survival and regeneration of adult human and other mammalian photoreceptors in culture

Investigative ophthalmology & visual science, 1996-10, Vol.37 (11), p.2258

1996

Volltextzugriff (PDF)

Heterogeneity of Serum IgG Subclass Deficiencies in B Chronic Lymphocytic Leukemia

Clinical immunology (Orlando, Fla.), 1999-01, Vol.90 (1), p.128-132

1999

Volltextzugriff (PDF)

Surgery of acute type A dissection: what have we learned during the past 25 years?

Clinical research in cardiology, 2000-10, Vol.89 Suppl 7 (S7), p.47-54

2000

Volltextzugriff (PDF)

Proliferative Response of B Chronic Lymphocytic Leukemia Lymphocytes Stimulated with IL2 and Soluble CD23

Leukemia & lymphoma, 1994, Vol.14 (3-4), p.311-318

1994

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionOvid

KollektionSpringerLink (Online service)

Nur zeigenMit Volltextzugriff

ThemaAged, 80 And Over

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(25)
Französisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

Survival and regeneration of adult human and other mammalian photoreceptors in culture

Heterogeneity of Serum IgG Subclass Deficiencies in B Chronic Lymphocytic Leukemia

Surgery of acute type A dissection: what have we learned during the past 25 years?

Proliferative Response of B Chronic Lymphocytic Leukemia Lymphocytes Stimulated with IL2 and Soluble CD23

Aktive Filter

Suchergebnisse filtern